Biostar Pharmaceuticals, Inc.
BSPMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$264
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Biostar Pharmaceuticals, Inc. (BSPM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BSPM · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2017Report Date: Nov 20, 2017EPS Actual
-$0.05
Revenue
—
Fiscal Period
Q4 FY2017
FY ends December
Report Date
Nov 20, 2017
After Market Close
BSPM reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2018 | Apr 13, 2018 | — | — | — | — | — | — |
| — Q4 FY2017 | Nov 20, 2017 | — | -$0.05 | — | — | — | — |
| — Q3 FY2017 | Sep 30, 2017 | — | -$0.25 | — | — | — | — |
| — Q2 FY2017 | May 19, 2017 | — | -$0.38 | — | — | — | — |
| — Q2 FY2017 | Apr 13, 2017 | — | $1.63 | — | — | — | — |
| — Q4 FY2016 | Nov 21, 2016 | — | -$0.71 | — | $0.00B | — | — |
| — Q3 FY2016 | Aug 22, 2016 | — | -$3.12 | — | $0.00B | — | — |
| — Q2 FY2016 | May 23, 2016 | — | -$0.28 | — | $0.00B | — | — |
Q2 FY2018
Apr 13, 2018
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2017
Nov 20, 2017
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2017
Sep 30, 2017
EPS Actual
-$0.25
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2017
May 19, 2017
EPS Actual
-$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2017
Apr 13, 2017
EPS Actual
$1.63
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2016
Nov 21, 2016
EPS Actual
-$0.71
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2016
Aug 22, 2016
EPS Actual
-$3.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2016
May 23, 2016
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for BSPM.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2017 | Nov 20, 2017 | — | $1.96 | $1.80 | -8.16% |
| — Q3 FY2017 | Sep 30, 2017 | — | $1.29 | $1.37 | +6.20% |
| — Q2 FY2017 | May 19, 2017 | — | $1.66 | $1.73 | +4.22% |
| — Q2 FY2017 | Apr 13, 2017 | — | $2.27 | $2.28 | +0.44% |
| — Q4 FY2016 | Nov 21, 2016 | — | $3.09 | $3.42 | +10.68% |
| — Q3 FY2016 | Aug 22, 2016 | — | $4.05 | $4.06 | +0.25% |
| — Q2 FY2016 | May 23, 2016 | — | $1.30 | $1.25 | -3.98% |
| — Q1 FY2016 | Mar 31, 2016 | — | $2.12 | $1.91 | -9.91% |
Q4 FY2017-8.16%
Report Date
Nov 20, 2017
EPS Beat/Miss
—
Price Before
$1.96
Price After
$1.80
Q3 FY2017+6.20%
Report Date
Sep 30, 2017
EPS Beat/Miss
—
Price Before
$1.29
Price After
$1.37
Q2 FY2017+4.22%
Report Date
May 19, 2017
EPS Beat/Miss
—
Price Before
$1.66
Price After
$1.73
Q2 FY2017+0.44%
Report Date
Apr 13, 2017
EPS Beat/Miss
—
Price Before
$2.27
Price After
$2.28
Q4 FY2016+10.68%
Report Date
Nov 21, 2016
EPS Beat/Miss
—
Price Before
$3.09
Price After
$3.42
Q3 FY2016+0.25%
Report Date
Aug 22, 2016
EPS Beat/Miss
—
Price Before
$4.05
Price After
$4.06
Q2 FY2016-3.98%
Report Date
May 23, 2016
EPS Beat/Miss
—
Price Before
$1.30
Price After
$1.25
Q1 FY2016-9.91%
Report Date
Mar 31, 2016
EPS Beat/Miss
—
Price Before
$2.12
Price After
$1.91
Beat Rate0 / 8 quarters
Largest Move+10.68% (Q4 FY2016)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BSPM ends December
Biostar Pharmaceuticals, Inc. (BSPM) most recently reported earnings on November 20, 2017 for Q4 FY2017, posting EPS of $-0.05 (in line with the analyst consensus of —). The next BSPM earnings date is expected around September 1, 2026.
Each quarter, investors track BSPM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BSPM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BSPM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BSPM earnings · 4 questionsBiostar Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. BSPM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BSPM historically reports after market close (AMC).
BSPM earnings datewhen is BSPM earningsBSPM next earnings datewhen does BSPM report earningsBSPM earnings calendar
▸ Source: FMP · Biostar Pharmaceuticals, Inc. SEC filings · US GAAP · Biostar Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026